Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare
Fierce Healthcare
No deal in sight following high-stakes White House negotiations
ACA subsidies remain a sticking point, though Schumer said the president appears more amenable to a compromise than other Republicans.
Dave Muoio
,
Emma Beavins
Sep 29, 2025 6:00pm
US price negotiations could hit R&D harder than expected: study
Sep 6, 2023 10:20am
Pain clinic settles Medicare, Medicaid fraud claims for $11.4M
Jul 28, 2023 12:48pm
DOJ cracks down on $1.2B in fraudulent telehealth tests
Jul 21, 2022 12:49pm
DOJ charges doctor in $46M Medicare fraud scheme
Jan 7, 2022 1:11pm
When the eye on older patients is a camera
Nov 23, 2021 9:35am